Related Experiment Video
Updated: Jun 19, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
[Thrombin and anticoagulant therapy]
Abstract:
New data which reveal rational approaches for pharmacologic control of blood coagulation process and confirm the key role of thrombin in haemostasis processes compared with other proteinases are presented in the review. Modulation of thrombin properties described in the review gives a new possibility for creating anti-thrombin preparations. Thrombin allosteria can serve a basis for development of new therapy. Creation of catalytically inert thrombin in slow-form within efficient anti-coagulant activity in vivo will allow using it in medicine as a unique anti-thrombin agent.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management